Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prins

Showing results (641-650 of 722) with videos related to

Pageof 73
Sort By:
The Journal of Clinical Investigation|September 1, 2023
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumorsLu Sun, Jenny C Kienzler, Jeremy G Reynoso, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastomaElisa Fazzari, Daria J Azizad, Matthew X Li, et al.
Cancer Immunology Research|November 7, 2019
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint InhibitionLouise W Treffers, Toine Ten Broeke, Thies Rösner, et al.
Cancer & Metabolism|April 26, 2018
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilitiesMatthew Garrett, Jantzen Sperry, Daniel Braas, et al.
Gastroenterology|August 31, 2010
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virusTheodora E M S de Vries-Sluijs, Jurriën G P Reijnders, Bettina E Hansen, et al.
Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.
NMR in Biomedicine|June 15, 2022
Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumorsNicholas S Cho, Akifumi Hagiwara, Jingwen Yao, et al.
British Journal of Clinical Pharmacology|October 10, 2022
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation studyManon L M Prins, Johan L van der Plas, Maurits F J M Vissers, et al.
Signal Transduction and Targeted Therapy|April 17, 2023
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Ping Tan, Moe Ishihara, et al.
The Journal of Antimicrobial Chemotherapy|March 10, 2023
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort studyD T P Buis, T W van der Vaart, J M Prins, et al.
Pageof 73

Showing results (641-650 of 722) with videos related to

Sort By:
Pageof 73
The Journal of Clinical Investigation|September 1, 2023
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumorsLu Sun, Jenny C Kienzler, Jeremy G Reynoso, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastomaElisa Fazzari, Daria J Azizad, Matthew X Li, et al.
Cancer Immunology Research|November 7, 2019
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint InhibitionLouise W Treffers, Toine Ten Broeke, Thies Rösner, et al.
Cancer & Metabolism|April 26, 2018
Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilitiesMatthew Garrett, Jantzen Sperry, Daniel Braas, et al.
Gastroenterology|August 31, 2010
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virusTheodora E M S de Vries-Sluijs, Jurriën G P Reijnders, Bettina E Hansen, et al.
Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.
NMR in Biomedicine|June 15, 2022
Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumorsNicholas S Cho, Akifumi Hagiwara, Jingwen Yao, et al.
British Journal of Clinical Pharmacology|October 10, 2022
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation studyManon L M Prins, Johan L van der Plas, Maurits F J M Vissers, et al.
Signal Transduction and Targeted Therapy|April 17, 2023
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Ping Tan, Moe Ishihara, et al.
The Journal of Antimicrobial Chemotherapy|March 10, 2023
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort studyD T P Buis, T W van der Vaart, J M Prins, et al.
Pageof 73